Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply
Resilience and Lilly expand strategic partnership first established in 2023 Investment will significantly increase U.S. production of Lilly’s...
BLOG
Read on
Resilience Announces Relocation of West Coast Headquarters to Ohio and Expansion of Sterile Manufacturing Capabilities
BLUE ASH, Ohio, June 18, 2026 – Resilience, along with Ohio Governor Mike DeWine, JobsOhio, the City of Blue Ash, and REDI Cincinnati, today...
Boston, MA: Process & Analytical Development and Manufacturing Facility
The launch of our Process & Analytical Development and Manufacturing Facility marks a strategic resurgence in the Boston area, as we consolidate and...
Meet the Team: Viral Vector Development & Manufacturing
Meet Kyle Anderson, Ph.D., Director of Manufacturing Science and Technology (MSAT) at Resilience RTP, North Carolina & Xiaotong Fu, Ph.D., Head of...
Alachua Campus Tour Video
With a sustainable network of high-tech, end-to-end manufacturing facilities across North America, Resilience has become a powerhouse in how...
On-demand Video: Efficiency Meets Economy: The Power of Single-Use Chromatography in mAb Purification
Read on
Alachua Biomanufacturing Expansion Video
We are remaking the way medicines are made and that starts with our facilities. At our Alachua, Florida campus, Building G defines the future of our...
